Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE)

Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE)

Background: Lassa Fever (LF), is a severe viral disease prevalent in Western Africa. It is classified as a priority disease by the World Health Organization (WHO). Ribavirin is the recommended therapy despite weak evidence of its efficacy. Promising therapeutic agents are becoming available for eval...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Duvignaud, A, Jaspard, M, Etafo, IC, Serra, B, Abejegah, C, Gabillard, D, Doutchi, M, Alabi, JF, Adedokun, MA, Akinpelu, AO, Oyegunle, OO, Etafo, J, Dede, AO, Onyechi, MN, Ireneh, MU, Gbenga-Ayeni, O, Fadiminiyi, KG, Ehigbor, PI, Ouattara, E, Levy-Marchal, C, Karcher, S, N'guessan-Koffi, L, Ahyi, I, Amani, E, Diabaté, M, Siloué, B, Schaeffer, J, Augier, A, Ogbaini-Emovon, E, Salam, AP, Horby, P, Ahmed, LA, Günther, S, Adedosu, AN, Anglaret, X, Ayodeji, OO, Malvy, D
Fformat: Journal article
Iaith:English
Cyhoeddwyd: Elsevier 2020

Eitemau Tebyg